Showing 1 of 1 recruiting trials for “Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome”
A Study to Test the Safety of Pozelimab in Pediatric Participants 1 to 5 Years of Age With a Rare Disease Called CHAPLE (Complement Hyperactivation, Angiopathic Thrombosis, Protein-losing Enteropathy) Disease
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →